Uh Oh
Response from developer
Our system is working correctly. Please try again or contact us directly at the email address info@genomapp.com. Sorry for any inconvenience.
Great Presentation of Data
Only as good as the data you give it
Android to iPhone switching
The info the app gives is good to know. I like the detail. Too bad I paid for full reports and can’t access them now. The “Help” section has an FAQ that doesn’t include this or how to contact their customer service.
Amazing App
Great app!
When will new version be out? Thank you!!
Response from developer
Thank you! We are working on it and we hope it will be ready soon!
Nice but the table of contents are at the bottom for the exported pdf!
Surveys
Response from developer
First of all, please note that Genomapp does not access your DNA information, Genomapp is just a tool that allows you to compare your raw DNA data with scientific literature. Nor do we ask to contribute information. Besides that, Genomapp is not a subscription service.
No Update for 15 Months
15 months of wait for update is too long.
I’m afraid the app is abandoned.
Love App but Please Update
Response from developer
Thanks for your support! We are currently working on a major update.
Run!!!
Response from developer
Genomapp is not a subscription service. You must be referring to another app by mistake. If you need help transferring your file we would be glad to help. You can contact us at info@genomapp.com.
I’ve used Genomapp since 2015 and I love it!
Unable to delete account
Approach with extreme caution.
The Genomapp report stated that I had two copies of a pathogenic variation in a point in the BRCA1 gene. The other genetic testing company informed me that two copies of a pathogenic gene at that point would mean I would have never developed fully as embryo, been carried to term and then been born. It’s basically impossible to have two copies and survive til birth. One copy of the variant would be considered pathogenic. As it turned out with further testing I had no pathogenic BRCA1 variants. This makes me think there are deficits in the construction and design of the reports and not just a mistake in the original test.
Update after developer response:
The developer has missed the point, It is medically impossible to survive until birth with two copies of that marker. So even if the error is in the data rather than the report, that should have been picked up as an error rather than merely flagged as a pathogenic marker. Hence the title “Approach with extreme caution”.

